Linnea Achieves CEP Certification for Cannabidiol Isolate

Contributed by: Business Wire

Logo

Tags

Other Health

General Health

Other Retail

Cannabis

Pharmaceutical

Other Natural Resources

Natural Resources

Fitness & Nutrition

Cosmetics

Retail

Alternative Medicine

Vitamins/Supplements

Health

Linnea

More Like This

Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of Medicines & Healthcare

PR Newswire associated0

Curaleaf International Launches CPD-Accredited Medical Cannabis Education Platform for UK Healthcare Professionals

First Cannabis full-spectrum product, manufactured in Brazil by Ease Labs, is approved by the local Health Regulatory Agency

CBD is approved for treatment-resistant epilepsy in children, and recent trials suggest that it may be useful for treating other disorders, such as schizophrenia and anxiety. Photo credit: Julia Zolotova

Quolet announces completion of Phase 1 healthy volunteer study evaluating the safety and bioavailability of Cannabidiol in a novel formulation intended for treatment of various neurological and psychiatric diseases

Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany

Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development

Tilray Medical Receives Approval for First Medical Cannabis Extract in Portugal